Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Article in Journal of Gastroenterology (February 2023)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
Article in Internal Medicine (November 2022)
Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV)
Article in Expert Review of Anti-infective Therapy (September 2022)